Class I histocompatibility antigen expression: A prognostic factor for aneuploid ovarian cancers

1990 ◽  
Vol 38 (3) ◽  
pp. 458-461 ◽  
Author(s):  
David H. Moore ◽  
Wesley C. Fowler ◽  
Karl Olafsson
Pathology ◽  
1987 ◽  
Vol 19 (4) ◽  
pp. 339-346 ◽  
Author(s):  
Gennaro D’Alessandro ◽  
Peter Hersey ◽  
Ibrahim Zardawi ◽  
Julienne Grace ◽  
William H. McCarthy

1985 ◽  
Vol 22 (6) ◽  
pp. 543-552 ◽  
Author(s):  
P. D�mant ◽  
M. Oudshoorn-Snoek

H-2 Antigens ◽  
1987 ◽  
pp. 611-622
Author(s):  
John G. Frelinger ◽  
Karen M. Cerosaletti ◽  
David W. Bahler ◽  
Lee W. Harwell ◽  
Edith M. Lord

Author(s):  
Alexander A. Celik ◽  
Rainer Blasczyk ◽  
Christina Bade-Döding

Blood ◽  
1988 ◽  
Vol 71 (2) ◽  
pp. 516-519
Author(s):  
J Pereira ◽  
C Cretney ◽  
RH Aster

Platelet alloantigens and other surface markers were studied in platelet cohorts of different mean density, using monoclonal and polyclonal probes. High density (HD) platelets expressed 12% more P1A1 molecules (46,942) than low density (LD) platelets (41,892). However, LD platelets carried 42% more HLA-A2 molecules (6,267 +/- 184) than HD platelets (4,406 +/- 232) (P less than .01) and 55% more class I HLA antigens (17,034 +/- 2,062 v 11,007 +/- 2,190) (P = .05). The platelet subpopulations did not differ in their content of glycoprotein (GP)IIb/IIIa complex or Baka antigen. The difference in expression of class I HLA antigens on HD and LD platelets is consistent with two possibilities: either class I HLA molecules are acquired from plasma or they are released into plasma as platelets age in circulation. Accordingly, class I HLA molecules may provide a useful marker of platelet age.


Sign in / Sign up

Export Citation Format

Share Document